Industry

Life Sciences and Health Care

Navigating complexities in the life sciences and health care industries is no easy task. Successfully competing in the space requires a partner with a holistic, collaborative approach and a global perspective. It calls for a strategy informed by asking the right questions and rooted in identifying creative solutions to...

Hogan Lovells Publications

Understanding sunshine rules: how new transparency regulations in Europe are changing relationships between industry and healthcare professionals

Sunshine rules in Europe pose new challenges for the life sciences industry What you need to know about new EU regulations designed to shed light on financial relationships between...

Quick view Full view

Hogan Lovells Publications

The 3-D printing revolution: Opening the doors to new opportunities — and risks associated with IP infringement

As the use of 3-D printing has increased exponentially, so has its potential. Stella Wong, counsel focusing on patent litigation at our Hogan Lovells office in London, compares a 3-D...

Quick view Full view

Hogan Lovells Publications

FDA signals increasing focus on cybersecurity requirements

With the continued explosion of software and software-controlled medical devices, including the growing use of machine learning and artificial intelligence, the FDA (the Agency) Medical...

Quick view Full view

Hogan Lovells Publications

FDA finalizes guidances for NGS-based tests

On April 12, 2018, the U.S. Food and Drug Administration (FDA or the Agency) finalized two guidances on the oversight of next generation sequencing (NGS)-based in vitro diagnostic tests....

Quick view Full view

Hogan Lovells Publications

Employment alert: April 2018

In this month's issue of our newsletter on employment matters in Poland:

Quick view Full view

Hogan Lovells Publications

Seeking to reduce premarket burdens, FDA proposes to expand Abbreviated 510(k) Pathway for certain devices

Building on recent efforts to streamline premarket review of medical devices, on April 12, 2018, the Food and Drug Administration (FDA) issued a draft guidance seeking to expand use of the ...

Quick view Full view
Loading data